کد مقاله کد نشریه سال انتشار مقاله انگلیسی نسخه تمام متن
3295447 1209855 2012 13 صفحه PDF دانلود رایگان
عنوان انگلیسی مقاله ISI
Maintenance of Remission Among Patients With Crohn's Disease on Antimetabolite Therapy After Infliximab Therapy Is Stopped
موضوعات مرتبط
علوم پزشکی و سلامت پزشکی و دندانپزشکی بیماری‌های گوارشی
پیش نمایش صفحه اول مقاله
Maintenance of Remission Among Patients With Crohn's Disease on Antimetabolite Therapy After Infliximab Therapy Is Stopped
چکیده انگلیسی
Approximately 50% of patients with Crohn's disease who were treated for at least 1 year with infliximab and an antimetabolite agent experienced a relapse within 1 year after discontinuation of infliximab. However, patients with a low risk of relapse can be identified using a combination of clinical and biologic markers.
ناشر
Database: Elsevier - ScienceDirect (ساینس دایرکت)
Journal: Gastroenterology - Volume 142, Issue 1, January 2012, Pages 63-70.e5
نویسندگان
, , , , , , , , , , , , , ,